BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dimai HP, Fahrleitner-Pammer A. Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions. Best Pract Res Clin Rheumatol 2022;36:101780. [PMID: 36163230 DOI: 10.1016/j.berh.2022.101780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan MI. Management of bone loss due to endocrine therapy during cancer treatment. Osteoporos Int 2023. [PMID: 36656338 DOI: 10.1007/s00198-023-06672-3] [Reference Citation Analysis]
2 Oh MS, Kim SI, Sim YE, Park SH, Kang MK, Kang IJ, Lim SS, Kang YH. Cirsium Setidens Water Extracts Containing Linarin Block Estrogen Deprivation-Induced Bone Loss in Mice. Int J Mol Sci 2023;24. [PMID: 36675135 DOI: 10.3390/ijms24021620] [Reference Citation Analysis]
3 Zhang W, Luo Y, Xu J, Guo C, Shi J, Li L, Sun X, Kong Q. The Possible Role of Electrical Stimulation in Osteoporosis: A Narrative Review. Medicina (Kaunas) 2023;59. [PMID: 36676745 DOI: 10.3390/medicina59010121] [Reference Citation Analysis]
4 Åkesson KE, Woolf AD. Osteoporosis and fragility fractures - Why is there still avoidable disability and death? Best Pract Res Clin Rheumatol 2022;36:101792. [PMID: 36371364 DOI: 10.1016/j.berh.2022.101792] [Reference Citation Analysis]